Global Recombinant DNA Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant DNA Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant DNA Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant DNA Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Recombinant DNA Vaccine Segment by Type

2.2.1 Recombinant Protein Vaccine

2.2.2 Gene-Based Vaccine

2.3 Recombinant DNA Vaccine Sales by Type

2.3.1 Global Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant DNA Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant DNA Vaccine Sale Price by Type (2017-2022)

2.4 Recombinant DNA Vaccine Segment by Application

2.4.1 Human

2.4.2 Animal

2.5 Recombinant DNA Vaccine Sales by Application

2.5.1 Global Recombinant DNA Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant DNA Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant DNA Vaccine Sale Price by Application (2017-2022)

3 Global Recombinant DNA Vaccine by Company

3.1 Global Recombinant DNA Vaccine Breakdown Data by Company

3.1.1 Global Recombinant DNA Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant DNA Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Recombinant DNA Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant DNA Vaccine Revenue by Company (2020-2022)

3.2.2 Global Recombinant DNA Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant DNA Vaccine Sale Price by Company

3.4 Key Manufacturers Recombinant DNA Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant DNA Vaccine Product Location Distribution

3.4.2 Players Recombinant DNA Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant DNA Vaccine by Geographic Region

4.1 World Historic Recombinant DNA Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant DNA Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant DNA Vaccine Annual Revenue by Geographic Region

4.2 World Historic Recombinant DNA Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant DNA Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant DNA Vaccine Annual Revenue by Country/Region

4.3 Americas Recombinant DNA Vaccine Sales Growth

4.4 APAC Recombinant DNA Vaccine Sales Growth

4.5 Europe Recombinant DNA Vaccine Sales Growth

4.6 Middle East & Africa Recombinant DNA Vaccine Sales Growth

5 Americas

5.1 Americas Recombinant DNA Vaccine Sales by Country

5.1.1 Americas Recombinant DNA Vaccine Sales by Country (2017-2022)

5.1.2 Americas Recombinant DNA Vaccine Revenue by Country (2017-2022)

5.2 Americas Recombinant DNA Vaccine Sales by Type

5.3 Americas Recombinant DNA Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant DNA Vaccine Sales by Region

6.1.1 APAC Recombinant DNA Vaccine Sales by Region (2017-2022)

6.1.2 APAC Recombinant DNA Vaccine Revenue by Region (2017-2022)

6.2 APAC Recombinant DNA Vaccine Sales by Type

6.3 APAC Recombinant DNA Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant DNA Vaccine by Country

7.1.1 Europe Recombinant DNA Vaccine Sales by Country (2017-2022)

7.1.2 Europe Recombinant DNA Vaccine Revenue by Country (2017-2022)

7.2 Europe Recombinant DNA Vaccine Sales by Type

7.3 Europe Recombinant DNA Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant DNA Vaccine by Country

8.1.1 Middle East & Africa Recombinant DNA Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant DNA Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant DNA Vaccine Sales by Type

8.3 Middle East & Africa Recombinant DNA Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant DNA Vaccine

10.3 Manufacturing Process Analysis of Recombinant DNA Vaccine

10.4 Industry Chain Structure of Recombinant DNA Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant DNA Vaccine Distributors

11.3 Recombinant DNA Vaccine Customer

12 World Forecast Review for Recombinant DNA Vaccine by Geographic Region

12.1 Global Recombinant DNA Vaccine Market Size Forecast by Region

12.1.1 Global Recombinant DNA Vaccine Forecast by Region (2023-2028)

12.1.2 Global Recombinant DNA Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant DNA Vaccine Forecast by Type

12.7 Global Recombinant DNA Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Recombinant DNA Vaccine Product Offered

13.1.3 Merck Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Recombinant DNA Vaccine Product Offered

13.2.3 GSK Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Recombinant DNA Vaccine Product Offered

13.3.3 Sanofi Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Zoties

13.4.1 Zoties Company Information

13.4.2 Zoties Recombinant DNA Vaccine Product Offered

13.4.3 Zoties Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Zoties Main Business Overview

13.4.5 Zoties Latest Developments

13.5 Elanco

13.5.1 Elanco Company Information

13.5.2 Elanco Recombinant DNA Vaccine Product Offered

13.5.3 Elanco Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elanco Main Business Overview

13.5.5 Elanco Latest Developments

13.6 Boehringer-Ingelheim

13.6.1 Boehringer-Ingelheim Company Information

13.6.2 Boehringer-Ingelheim Recombinant DNA Vaccine Product Offered

13.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer-Ingelheim Main Business Overview

13.6.5 Boehringer-Ingelheim Latest Developments

13.7 Indian Immunologicals

13.7.1 Indian Immunologicals Company Information

13.7.2 Indian Immunologicals Recombinant DNA Vaccine Product Offered

13.7.3 Indian Immunologicals Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Indian Immunologicals Main Business Overview

13.7.5 Indian Immunologicals Latest Developments

13.8 Plumbline Life Sciences

13.8.1 Plumbline Life Sciences Company Information

13.8.2 Plumbline Life Sciences Recombinant DNA Vaccine Product Offered

13.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Plumbline Life Sciences Main Business Overview

13.8.5 Plumbline Life Sciences Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant DNA Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant DNA Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Protein Vaccine

Table 4. Major Players of Gene-Based Vaccine

Table 5. Global Recombinant DNA Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Recombinant DNA Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Recombinant DNA Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Recombinant DNA Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Recombinant DNA Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Recombinant DNA Vaccine Revenue by Application (2017-2022)

Table 13. Global Recombinant DNA Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Recombinant DNA Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Recombinant DNA Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Recombinant DNA Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Recombinant DNA Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Recombinant DNA Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Recombinant DNA Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Recombinant DNA Vaccine Producing Area Distribution and Sales Area

Table 21. Players Recombinant DNA Vaccine Products Offered

Table 22. Recombinant DNA Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Recombinant DNA Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Recombinant DNA Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Recombinant DNA Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Recombinant DNA Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Recombinant DNA Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Recombinant DNA Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Recombinant DNA Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Recombinant DNA Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Recombinant DNA Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Recombinant DNA Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Recombinant DNA Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Recombinant DNA Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Recombinant DNA Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Recombinant DNA Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Recombinant DNA Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Recombinant DNA Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Recombinant DNA Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Recombinant DNA Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Recombinant DNA Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Recombinant DNA Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Recombinant DNA Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Recombinant DNA Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Recombinant DNA Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Recombinant DNA Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Recombinant DNA Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Recombinant DNA Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Recombinant DNA Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Recombinant DNA Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Recombinant DNA Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Recombinant DNA Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Recombinant DNA Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Recombinant DNA Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Recombinant DNA Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Recombinant DNA Vaccine

Table 66. Key Market Challenges & Risks of Recombinant DNA Vaccine

Table 67. Key Industry Trends of Recombinant DNA Vaccine

Table 68. Recombinant DNA Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Recombinant DNA Vaccine Distributors List

Table 71. Recombinant DNA Vaccine Customer List

Table 72. Global Recombinant DNA Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Recombinant DNA Vaccine Sales Market Forecast by Region

Table 74. Global Recombinant DNA Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Recombinant DNA Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Recombinant DNA Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Recombinant DNA Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Recombinant DNA Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Recombinant DNA Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Recombinant DNA Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Recombinant DNA Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Recombinant DNA Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Recombinant DNA Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Recombinant DNA Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Recombinant DNA Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Recombinant DNA Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Recombinant DNA Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Recombinant DNA Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Recombinant DNA Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Recombinant DNA Vaccine Product Offered

Table 94. Merck Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. GSK Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Recombinant DNA Vaccine Product Offered

Table 99. GSK Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Sanofi Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Recombinant DNA Vaccine Product Offered

Table 104. Sanofi Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Zoties Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Zoties Recombinant DNA Vaccine Product Offered

Table 109. Zoties Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Zoties Main Business

Table 111. Zoties Latest Developments

Table 112. Elanco Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Elanco Recombinant DNA Vaccine Product Offered

Table 114. Elanco Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Elanco Main Business

Table 116. Elanco Latest Developments

Table 117. Boehringer-Ingelheim Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Boehringer-Ingelheim Recombinant DNA Vaccine Product Offered

Table 119. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Boehringer-Ingelheim Main Business

Table 121. Boehringer-Ingelheim Latest Developments

Table 122. Indian Immunologicals Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Indian Immunologicals Recombinant DNA Vaccine Product Offered

Table 124. Indian Immunologicals Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Indian Immunologicals Main Business

Table 126. Indian Immunologicals Latest Developments

Table 127. Plumbline Life Sciences Basic Information, Recombinant DNA Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Plumbline Life Sciences Recombinant DNA Vaccine Product Offered

Table 129. Plumbline Life Sciences Recombinant DNA Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Plumbline Life Sciences Main Business

Table 131. Plumbline Life Sciences Latest Developments

List of Figures

Figure 1. Picture of Recombinant DNA Vaccine

Figure 2. Recombinant DNA Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant DNA Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Recombinant DNA Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant DNA Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Protein Vaccine

Figure 10. Product Picture of Gene-Based Vaccine

Figure 11. Global Recombinant DNA Vaccine Sales Market Share by Type in 2021

Figure 12. Global Recombinant DNA Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Recombinant DNA Vaccine Consumed in Human

Figure 14. Global Recombinant DNA Vaccine Market: Human (2017-2022) & (K Units)

Figure 15. Recombinant DNA Vaccine Consumed in Animal

Figure 16. Global Recombinant DNA Vaccine Market: Animal (2017-2022) & (K Units)

Figure 17. Global Recombinant DNA Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Recombinant DNA Vaccine Revenue Market Share by Application in 2021

Figure 19. Recombinant DNA Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Recombinant DNA Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Recombinant DNA Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Recombinant DNA Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Recombinant DNA Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Recombinant DNA Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Recombinant DNA Vaccine Sales 2017-2022 (K Units)

Figure 26. Americas Recombinant DNA Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Recombinant DNA Vaccine Sales 2017-2022 (K Units)

Figure 28. APAC Recombinant DNA Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Recombinant DNA Vaccine Sales 2017-2022 (K Units)

Figure 30. Europe Recombinant DNA Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Recombinant DNA Vaccine Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Recombinant DNA Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Recombinant DNA Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Recombinant DNA Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Recombinant DNA Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Recombinant DNA Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Recombinant DNA Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Recombinant DNA Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Recombinant DNA Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Recombinant DNA Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Recombinant DNA Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Recombinant DNA Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Recombinant DNA Vaccine

Figure 63. Industry Chain Structure of Recombinant DNA Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles